Ovarian stimulation protocol for in vitro fertilization with gonadotropin-releasing hormone agonist widens the implantation window*†*Presented in part at the 36th Annual Meeting of The Society for Gynecologic Investigation, San Diego, California, March 15 to 18, 1989.†Supported in part by The Foundation for Reproductive Medicine, Inc., Chicago, Illinois.
- 1 May 1990
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 53 (5), 859-864
- https://doi.org/10.1016/s0015-0282(16)53522-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A Controlled Study of Luteinizing Hormone–Releasing Hormone Agonist (Buserelin) for the Induction of Folliculogenesis before in Vitro FertilizationNew England Journal of Medicine, 1989
- Hormonal Manipulation of Endometrial MaturationJournal of Clinical Endocrinology & Metabolism, 1989
- Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrievalFertility and Sterility, 1989
- Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormoneHuman Reproduction, 1989
- In vitro fertilization: the degree of endometrial insufficiency varies with the type of ovarian stimulationFertility and Sterility, 1988
- Incidence of Early Loss of PregnancyNew England Journal of Medicine, 1988
- Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormoneBMJ, 1988
- Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropinsFertility and Sterility, 1987
- Factors influencing pregnancy rates following in vitro fertilization and embryo transferFertility and Sterility, 1985
- Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancyFertility and Sterility, 1982